Bone marrow evaluation in small cell carcinoma of the lung

G. Giaccone, L. Ciuffreda, M. Donadio, P. Ferrati, M. Risio, G. Leria, G. Bonardi, A. Calciati

Research output: Contribution to journalArticlepeer-review


Bone marrow examination is commonly included in the staging of small cell lung carcinoma (SCLC). We reviewed marrow samples of 103 patients. Marrow examination was mainly performed by unilateral or bilateral biopsy of iliac crests, using a Jamshidi needle. Only 6 of 97 evaluable cases (6.2 per cent) were positive for marrow metastases at staging, and in 3 cases (3 per cent) bone marrow was the only metastatic site. No focal metastases were found in additional sections made from the blocks of negative samples. In our experience bone marrow biopsy was of little value in staging SCLC. Bilateral biopsy plus aspirate, with the addition of more sophisticated staining techniques might, however, provide a higher yield of positive marrow involvement.

Original languageEnglish
Pages (from-to)185-188
Number of pages4
JournalActa Oncologica
Issue number3
Publication statusPublished - 1987


  • Bone marrow biopsy
  • Lung neoplasms
  • Small cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology


Dive into the research topics of 'Bone marrow evaluation in small cell carcinoma of the lung'. Together they form a unique fingerprint.

Cite this